Search research articles
Contact Us
Filters
Showing results (71-80 of 124) with videos related to
Page
of 13
Sort By:
Cell Reports
|
September 12, 2019
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors
Malik Lutzmann, Florence Bernex, Cindy da Costa de Jesus, et al.
Leukemia
|
February 20, 2024
Deregulation of the p19/CDK4/CDK6 axis in Jak2<sup>V617F</sup> megakaryocytes accelerates the development of myelofibrosis
Hélène Duparc, Delphine Muller, Laure Gilles, et al.
The Journal of Experimental Medicine
|
October 19, 2020
JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML
Tracy Dagher, Nabih Maslah, Valérie Edmond, et al.
Iscience
|
January 15, 2025
Monocytes generated by interleukin-6-treated human hematopoietic stem and progenitor cells secrete calprotectin that inhibits erythropoiesis
Valentine Marchand, Lucie Laplane, Louis Valensi, et al.
Blood
|
November 8, 2019
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms
Christian A Di Buduo, Vittorio Abbonante, Caroline Marty, et al.
Journal of Cellular and Molecular Medicine
|
December 21, 2016
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0
Vladimir T Manchev, Hind Bouzid, Iléana Antony-Debré, et al.
Stem Cell Research
|
March 21, 2020
TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells
Lise Secardin, Cintia Elisabeth Gomez Limia, Antonio di Stefano, et al.
The Journal of Clinical Investigation
|
April 29, 2021
PPARγ agonists promote the resolution of myelofibrosis in preclinical models
Juliette Lambert, Joseph Saliba, Carolina Calderon, et al.
Scientific Reports
|
November 26, 2016
CXCR4/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress
Yanyan Zhang, Mallorie Dépond, Liang He, et al.
Hemasphere
|
June 16, 2021
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms
Lise Secardin, Cintia Gomez Limia, Suzana da Silva-Benedito, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 124) with videos related to
Sort By:
Page
of 13
Cell Reports
|
September 12, 2019
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors
Malik Lutzmann, Florence Bernex, Cindy da Costa de Jesus, et al.
Leukemia
|
February 20, 2024
Deregulation of the p19/CDK4/CDK6 axis in Jak2<sup>V617F</sup> megakaryocytes accelerates the development of myelofibrosis
Hélène Duparc, Delphine Muller, Laure Gilles, et al.
The Journal of Experimental Medicine
|
October 19, 2020
JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML
Tracy Dagher, Nabih Maslah, Valérie Edmond, et al.
Iscience
|
January 15, 2025
Monocytes generated by interleukin-6-treated human hematopoietic stem and progenitor cells secrete calprotectin that inhibits erythropoiesis
Valentine Marchand, Lucie Laplane, Louis Valensi, et al.
Blood
|
November 8, 2019
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms
Christian A Di Buduo, Vittorio Abbonante, Caroline Marty, et al.
Journal of Cellular and Molecular Medicine
|
December 21, 2016
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0
Vladimir T Manchev, Hind Bouzid, Iléana Antony-Debré, et al.
Stem Cell Research
|
March 21, 2020
TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells
Lise Secardin, Cintia Elisabeth Gomez Limia, Antonio di Stefano, et al.
The Journal of Clinical Investigation
|
April 29, 2021
PPARγ agonists promote the resolution of myelofibrosis in preclinical models
Juliette Lambert, Joseph Saliba, Carolina Calderon, et al.
Scientific Reports
|
November 26, 2016
CXCR4/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress
Yanyan Zhang, Mallorie Dépond, Liang He, et al.
Hemasphere
|
June 16, 2021
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms
Lise Secardin, Cintia Gomez Limia, Suzana da Silva-Benedito, et al.
Page
of 13